Cite
APA Citation
Sukeishi, A., Itohara, K., Yonezawa, A., Sato, Y., Matsumura, K., Katada, Y., Nakagawa, T., Hamada, S., Tanabe, N., Imoto, E., Kai, S., Hirai, T., Yanagita, M., Ohtsuru, S., Terada, T., & Ito, I. (2022). population pharmacokinetic modeling of GS‐441524, the active metabolite of remdesivir, in Japanese COVID‐19 patients with renal dysfunction. CPT: pharmacometrics & systems pharmacology, 11, 94–103. http://access.bl.uk/ark:/81055/vdc_100148623622.0x000005